AbbVie
ABBV
ABBV
3,158 hedge funds and large institutions have $255B invested in AbbVie in 2022 Q4 according to their latest regulatory filings, with 363 funds opening new positions, 1,187 increasing their positions, 1,260 reducing their positions, and 101 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
0.19% less ownership
Funds ownership: 69.98% → 69.79% (-0.19%)
4% less call options, than puts
Call options by funds: $2.99B | Put options by funds: $3.13B
6% less repeat investments, than reductions
Existing positions increased: 1,187 | Existing positions reduced: 1,260
Holders
3,158
Holding in Top 10
348
Calls
$2.99B
Puts
$3.13B
Top Buyers
| 1 | +$881M | |
| 2 | +$734M | |
| 3 | +$503M | |
| 4 |
JP Morgan Chase
New York
|
+$373M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$352M |
Top Sellers
| 1 | -$2.59B | |
| 2 | -$628M | |
| 3 | -$432M | |
| 4 |
CIAS
CFS Investment Advisory Services
Totowa,
New Jersey
|
-$378M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$186M |